Search
for

    Glossary Bisphosphonates

    drugs that prevent bone density loss by inhibiting osteoclasts

    Bisphosphonates, also known as diphosphonates, are a class of drugs that prevent the loss of bone density. They are commonly prescribed to treat osteoporosis and similar bone diseases by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This helps to strengthen bones and reduce the risk of fractures.

    Research 10 of 145

    1. Dynamics of procollagen type 1 N-terminal propeptide in postmenopausal osteoporosis during bisphosphonate therapy and transcranial electrical stimulation International journal of medicine and psychology. · 2024
    2. Menopause and aging, quality of life and sexuality Climacteric · 2007 · 55 citations
    3. Gonadal dysgenesis and bone metabolism Joint bone spine · 2001 · 45 citations
    4. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    5. Menopause Elsevier eBooks · 2007 · 3 citations
    6. Skin manifestations of chronic kidney disease Actas Dermo-Sifiliográficas · 2015
    7. 14. Wound Healing; Cutaneous Therapy; Hair Medical & surgical dermatology · 2008
    8. Foreword Endocrinology and Metabolism Clinics of North America · 2007
    9. PRZYPADEK POLEKOWEJ MARTWICY ŻUCHWY (MRONJ) Wiadomości Lekarskie · 2024
    10. New approaches to the treatment of osteoporosis Current Opinion in Chemical Biology · 2000 · 28 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →